Table 2.
Effect of selenium supplementation on HIV-1 RNA detection in breast milk
| Selenium Group |
Selenium Group |
|||||
|---|---|---|---|---|---|---|
| Population | n | Detectable Viral Load Frequency (%) |
n | Detectable Viral Load Frequency (%) |
Relative Risk (95% CI) |
p-value |
| All Women | 209 | 76 (36.4) | 211 | 58 (27.5) | 1.32 (1.00–1.76) | 0.05 |
| Among All Women* | ||||||
| Women Receiving HAART | 8 | 0 (0) | 4 | 1 (25.0) | - | 0.14 |
| Women Not Receiving HAART | 201 | 76 (37.8) | 207 | 57 (27.5) | 1.37 (1.03–1.82) | 0.03 |
| Among Women Not Receiving HAART* | ||||||
| Primiparous Women | 49 | 26 (53.1) | 13 | 55 (23.6) | 2.24 (1.30–3.86) | <0.01 |
| Multiparous Women | 152 | 50 (32.9) | 211 | 58 (29.0) | 1.14 (0.81–1.59) | 0.54 |
p-value for interaction for receipt of HAART (p=0.07) and parity (p=0.02)